🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 18 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/01/2009 | 27,53 | 27,67 | 27,04 | 27,24 | -1,35% | 2,29% | 17.210.675 |
| 29/01/2009 | 27,21 | 27,73 | 27,08 | 27,61 | +0,56% | 2,38% | 12.581.974 |
| 28/01/2009 | 27,54 | 27,78 | 27,08 | 27,46 | +1,45% | 2,53% | 14.200.505 |
| 27/01/2009 | 26,58 | 27,36 | 26,57 | 27,07 | +2,09% | 2,94% | 10.106.178 |
| 26/01/2009 | 26,78 | 27,41 | 26,26 | 26,52 | -1,45% | 4,31% | 14.818.720 |
| 23/01/2009 | 26,47 | 27,05 | 26,27 | 26,91 | +2,73% | 2,96% | 15.603.986 |
| 22/01/2009 | 26,00 | 26,43 | 25,64 | 26,19 | -0,44% | 3,05% | 15.980.428 |
| 21/01/2009 | 26,94 | 27,09 | 25,66 | 26,31 | -1,15% | 5,31% | 19.101.477 |
| 20/01/2009 | 26,84 | 27,56 | 26,56 | 26,61 | -1,06% | 3,73% | 15.407.067 |
| 16/01/2009 | 27,10 | 27,44 | 26,15 | 26,90 | +0,25% | 4,75% | 15.213.711 |
| 15/01/2009 | 26,54 | 26,98 | 26,12 | 26,83 | +1,08% | 3,27% | 13.285.810 |
| 14/01/2009 | 26,65 | 26,97 | 26,15 | 26,55 | -2,18% | 3,08% | 12.828.987 |
| 13/01/2009 | 27,11 | 27,66 | 26,94 | 27,14 | -0,21% | 2,68% | 11.330.138 |
| 12/01/2009 | 27,41 | 27,62 | 27,00 | 27,19 | -0,80% | 2,26% | 9.313.157 |
| 09/01/2009 | 27,58 | 28,25 | 27,15 | 27,41 | -2,15% | 4,01% | 11.125.987 |
| 08/01/2009 | 28,32 | 28,33 | 27,71 | 28,02 | -0,44% | 2,19% | 11.092.137 |
| 07/01/2009 | 28,25 | 28,51 | 27,82 | 28,14 | -1,60% | 2,43% | 13.325.530 |
| 06/01/2009 | 29,66 | 29,83 | 28,20 | 28,60 | -1,83% | 5,50% | 15.752.698 |
| 05/01/2009 | 30,01 | 30,21 | 28,90 | 29,13 | -1,52% | 4,36% | 15.686.988 |
| 02/01/2009 | 29,06 | 29,69 | 28,92 | 29,58 | +1,97% | 2,66% | 12.793.355 |
| 31/12/2008 | 28,34 | 29,17 | 28,33 | 29,01 | +2,70% | 2,96% | 12.601.362 |
| 30/12/2008 | 27,35 | 28,30 | 27,35 | 28,24 | +4,59% | 3,49% | 11.546.130 |
| 29/12/2008 | 27,78 | 27,91 | 26,67 | 27,00 | -2,41% | 4,47% | 13.581.032 |
| 26/12/2008 | 28,05 | 28,15 | 27,43 | 27,67 | -0,92% | 2,55% | 4.039.726 |
| 24/12/2008 | 28,02 | 28,30 | 27,77 | 27,93 | -0,48% | 1,91% | 3.538.258 |
| 23/12/2008 | 28,02 | 28,84 | 27,85 | 28,06 | +1,10% | 3,51% | 19.325.120 |
| 22/12/2008 | 27,17 | 28,03 | 26,99 | 27,76 | +1,86% | 3,83% | 17.876.784 |
| 19/12/2008 | 26,77 | 27,74 | 26,38 | 27,25 | +2,96% | 5,06% | 27.899.751 |
| 18/12/2008 | 26,14 | 27,03 | 25,82 | 26,47 | +2,29% | 4,64% | 19.715.290 |
| 17/12/2008 | 25,94 | 26,56 | 25,70 | 25,88 | -2,83% | 3,31% | 14.852.151 |